Samsung just dropped $2.18B on peptides and RMTG is sitting here at 8 cents

Samsung Biologics just dropped like 2.18 billion dollars to buy a Swiss peptide company PolyPeptide Group its the biggest overseas acquisition theyve ever done and they did it specifically for the peptide and glp1 market

That tells you exactly where the money is flowing and guess what RMTG is already doing the same exact thing with Cellgenic and ISSCA on a way smaller scale

Look at their Q2 numbers again
They did 4.02 million in revenue in just one quarter which is up 309% year over year
Gross margins at 64%
Operating income was 565k
Training revenue was up 860% and product supplies were up 421%

This is not some shell company this is actual growth in the exact sector that Samsung just spent billions on

I know the debt on the balance sheet looks scary to people but if they are pulling in 4 mil a quarter and turning a profit the debt is not the issue anymore they can actually start servicing it with real cash flow instead of having to dilute to survive the game totally changes when you are profitable.

I look at this as a short term play over the next few months I think Q3 comes in around 8 million in revenue and thats going to be the big catalyst that gets people looking at the actual fundamentals

Dont buy anything based on what I say but look at the 10q and do your own math the sector is literally exploding right now numbers are numbers